BIOSCRIPT GROUP LIMITEDActive
Key figures
BIOSCRIPT GROUP LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2023/24Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £1,525,397 (101% of the profit for the year).
Filed accounts2019/20–2023/24
| 2019/20 | 2020/21 | 2021/22 | 2022/23 | 2023/24 | |
|---|---|---|---|---|---|
| Profit for the year | — | 1,505,636 | -7,588 | 19,643 | -10 |
| Cash at bank and in hand | — | 89 | 23 | 16 | 106 |
| Total assets | — | 110,678 | 110,612 | 110,605 | 110,695 |
| Total liabilities | 21,687 | 21,787 | 29,309 | 29,409 | 29,509 |
| Net assets / total equity | 495 | 69,141 | 61,553 | 81,196 | 81,186 |
| Average number of employees | 0 | 0 | 0 | 0 | 0 |
| Dividends paid | — | -1,525,397 | — | — | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: BIOSCRIPT GROUP LIMITED
Company
BIOSCRIPT GROUP LIMITED is a private limited company registered with Companies House under company number 09542360. It was incorporated on 14 Apr 2015. Its status is active. The registered office is in Macclesfield (SK10). Its nature of business (SIC 2007) is activities of other holding companies n.e.c. (64209).
Accounts
The latest accounts in the database are for 2023/24 (period ending 30 Sep 2024); the company files full accounts. Loss for the year was £10. Net assets were £81,186, down 0% on the previous year. Cash at bank and in hand was £106. Total assets were £110,695 and total liabilities £29,509. The company had an average of 0 employees. Figures are available for 5 financial years (2019/20–2023/24).
Control and charges
One person with significant control is registered. 3 of 3 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 6 Feb 2027.